Hims & Hers Health surged to $69.88 per share this afternoon, but it remains 106.85% above its mean target price of $33.78. There may still be room for more downwards movement — even after today's 19.5% drop. Analysts are giving the Large-Cap Medical and Nursing Services stock on average rating of hold, with target prices ranging from $18.0 to $85.0 per share.
Hims & Hers Health has an elevated short interest of 30.3%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 5.61. The company's insiders own 11.83% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. 80.0% of Hims & Hers Health shares are held by institutional investors, which indicates a high level of confidence in the stock.
Institutions Invested in Hims & Hers Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-12-31 | Blackrock Inc. | 14% | 30,107,523 | $2,103,913,624 |
| 2024-12-31 | Vanguard Group Inc | 10% | 20,257,116 | $1,415,567,210 |
| 2024-12-31 | Farallon Capital Management LLC | 4% | 8,377,000 | $585,384,736 |
| 2024-12-31 | State Street Corporation | 4% | 7,772,923 | $543,171,837 |
| 2024-12-31 | Renaissance Technologies, LLC | 3% | 6,951,152 | $485,746,482 |
| 2024-12-31 | Arrowstreet Capital, Limited Partnership | 3% | 6,304,202 | $440,537,618 |
| 2024-12-31 | Goldman Sachs Group Inc | 3% | 5,543,668 | $387,391,504 |
| 2024-12-31 | Geode Capital Management, LLC | 2% | 4,329,996 | $302,580,108 |
| 2024-12-31 | Morgan Stanley | 2% | 4,028,991 | $281,545,880 |
| 2024-12-31 | Wellington Management Group, LLP | 2% | 3,422,566 | $239,168,902 |
For these reasons, we consider that the Hims & Hers Health is the subject of negative market sentiment.
